Cargando…

Potential SARS-CoV-2 main protease inhibitors

The coronavirus disease 2019 (COVID-19) pandemic has prompted an urgent need for new treatment strategies. No target-specific drugs are currently available for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but new drug candidates targeting the viral replication cycle are being explor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Banerjee, Riddhidev, Perera, Lalith, Tillekeratne, L.M. Viranga
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724992/ https://www.ncbi.nlm.nih.gov/pubmed/33309533 http://dx.doi.org/10.1016/j.drudis.2020.12.005

Ejemplares similares

Computational Prediction of Potential Inhibitors of the Main Protease of SARS-CoV-2
por: Abel, Renata, et al.
Publicado: (2020)

Developing inhibitors of the SARS-CoV-2 main protease
por: Seitz, Christian, et al.
Publicado: (2022)

Allosteric inhibitors of the main protease of SARS-CoV-2
por: Samrat, Subodh Kumar, et al.
Publicado: (2022)

Structural Basis of Potential Inhibitors Targeting SARS-CoV-2 Main Protease
por: Mengist, Hylemariam Mihiretie, et al.
Publicado: (2021)

Triterpenic Acid Amides as Potential Inhibitors of the SARS-CoV-2 Main Protease
por: Baev, Dmitry S., et al.
Publicado: (2022)

Biochemical screening for SARS-CoV-2 main protease inhibitors
por: Coelho, Camila, et al.
Publicado: (2020)

Discovery and Mechanism of SARS-CoV-2 Main Protease Inhibitors
por: Huff, Sarah, et al.
Publicado: (2021)

Fullerene derivatives as inhibitors of the SARS-CoV-2 main protease
por: Katagishi, Daiki, et al.
Publicado: (2023)

Potent and biostable inhibitors of the main protease of SARS-CoV-2
por: Tsuji, Kohei, et al.
Publicado: (2022)

Virtual screening of approved drugs as potential SARS-CoV-2 main protease inhibitors
por: Jiménez-Alberto, Alicia, et al.
Publicado: (2020)

Rapid structure-based identification of potential SARS-CoV-2 main protease inhibitors
por: Sobhia, M Elizabeth, et al.
Publicado: (2021)

Review on development of potential inhibitors of SARS-CoV-2 main protease (M(Pro))
por: Katre, Soumya Gulab, et al.
Publicado: (2022)

Quinazolinone-Peptido-Nitrophenyl-Derivatives as Potential Inhibitors of SARS-CoV-2 Main Protease
por: Giang, Huynh-Nguyet-Huong, et al.
Publicado: (2023)

Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2′s main protease
por: Mahdi, Mohamed, et al.
Publicado: (2020)

A cyclic peptide inhibitor of the SARS-CoV-2 main protease
por: Kreutzer, Adam G., et al.
Publicado: (2021)

Fragment-based inhibitor design for SARS-CoV2 main protease
por: Andola, Priyanka, et al.
Publicado: (2022)

Discovery of 3CLpro inhibitor of SARS-CoV-2 main protease
por: Kuang, Yi, et al.
Publicado: (2023)

Multicomponent Synthesis of the SARS-CoV-2 Main Protease Inhibitor Nirmatrelvir
por: Preschel, H. Daniel, et al.
Publicado: (2023)

Non-conventional interactions of N3 inhibitor with the main protease of SARS-CoV and SARS-CoV-2
por: García-Gutiérrez, Ponciano, et al.
Publicado: (2021)

2-Pyridone natural products as inhibitors of SARS-CoV-2 main protease
por: Forrestall, Katrina L., et al.
Publicado: (2021)

Discovery of 2-thiobenzimidazoles as noncovalent inhibitors of SARS-CoV-2 main protease
por: Deodato, Davide, et al.
Publicado: (2022)

Microbial Natural Products as Potential Inhibitors of SARS-CoV-2 Main Protease (M(pro))
por: Sayed, Ahmed M., et al.
Publicado: (2020)

Potency, Safety, and Pharmacokinetic Profiles of Potential Inhibitors Targeting SARS-CoV-2 Main Protease
por: Mengist, Hylemariam Mihiretie, et al.
Publicado: (2021)

In silico investigation of potential inhibitors to main protease and spike protein of SARS-CoV-2 in propolis
por: Harisna, Azza Hanif, et al.
Publicado: (2021)

Identification of lactoferrin-derived peptides as potential inhibitors against the main protease of SARS-CoV-2
por: Zhao, Wenzhu, et al.
Publicado: (2022)

Discovery of Potential Inhibitors of SARS-CoV-2 Main Protease by a Transfer Learning Method
por: Zhang, Huijun, et al.
Publicado: (2023)

In silico Screening of Potential SARS-CoV-2 Main Protease Inhibitors from Thymus schimperi
por: Mengist, Hylemariam Mihiretie, et al.
Publicado: (2023)

Crystal structure of SARS-CoV-2 main protease in complex with protease inhibitor PF-07321332
por: Zhao, Yao, et al.
Publicado: (2021)

Insect protease inhibitors; promising inhibitory compounds against SARS-CoV-2 main protease
por: Hemmati, Seyed Ali, et al.
Publicado: (2022)

Screening and evaluation of approved drugs as inhibitors of main protease of SARS-CoV-2
por: Tripathi, Praveen Kumar, et al.
Publicado: (2020)

Identification of 14 Known Drugs as Inhibitors of the Main Protease of SARS-CoV-2
por: Ghahremanpour, Mohammad M., et al.
Publicado: (2020)

Design and Evaluation of Bispidine-Based SARS-CoV-2 Main Protease Inhibitors
por: Shcherbakov, Dmitriy, et al.
Publicado: (2021)

Challenges of short substrate analogues as SARS-CoV-2 main protease inhibitors
por: Ullrich, Sven, et al.
Publicado: (2021)

A Genetic Trap in Yeast for Inhibitors of SARS-CoV-2 Main Protease
por: Alalam, Hanna, et al.
Publicado: (2021)

Hit Expansion of a Noncovalent SARS-CoV-2 Main Protease Inhibitor
por: Glaser, Jens, et al.
Publicado: (2022)

Computational study on peptidomimetic inhibitors against SARS-CoV-2 main protease
por: Somboon, Tuanjai, et al.
Publicado: (2021)

Action of Dipeptidyl Peptidase‐4 Inhibitors on SARS‐CoV‐2 Main Protease
por: Nar, Herbert, et al.
Publicado: (2021)

Search of Novel Small Molecule Inhibitors for the Main Protease of SARS-CoV-2
por: Zhang, Wenfa, et al.
Publicado: (2023)

Protegrin-2, a potential inhibitor for targeting SARS-CoV-2 main protease M(pro)
por: Jan, Zainab, et al.
Publicado: (2023)

The SARS-CoV-2 main protease as drug target
por: Ullrich, Sven, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_efipg2uhum7j2ric9ai1hf89dn